Please enable Javascript
Upper Tract Urothelial Carcinoma
Advertisement
Defining the Biology of Upper Tract Urothelial Carcinoma and Therapy Implications
Christopher Wallis, MD, PhD, FRCSC
SUO 2023
|
December 1, 2023
Drs. Faltas and Wallis delve into the genomics of UTUC, including the evolution of disease and FGFR inhibition potential.
View More
Nephron-Sparing and Chemoablation in Upper Tract Urothelial Carcinoma
Christopher Wallis, MD, PhD, FRCSC
SUO 2023
|
December 1, 2023
Drs. Murray and Wallis discuss optimal patient selection, size criteria, and surgical ablation and chemoablation together.
View More
Nomogram Finds Suitable Candidates for Endoscopic Management of LG-NMI UTUC
Emily Menendez
Upper Tract Urothelial Carcinoma
|
November 21, 2023
The nomogram outperformed 2 conventional models in predictive accuracy and showed higher benefit in decision curve analysis.
Read More
Novel Use of ctDNA to Identify Muscle-Invasive, Non–Organ-Confined UTUC
Roger Li, MD
Upper Tract Urothelial Carcinoma
|
November 15, 2023
Dr. Li details what his study results suggested about ctDNA’s prognostic implications for survival in patients with UTUC.
View More
Ureteroscopic Surgery for Patients With UTUC
Katy Marshall
Upper Tract Urothelial Carcinoma
|
November 14, 2023
The study compared ureteroscopic surgery with radical nephroureterectomy.
Read More
Detection of ctDNA May Be an Effective Predictor for Muscle-Invasive, Non–Organ-Confined UTUC
Katy Marshall
Upper Tract Urothelial Carcinoma
|
November 10, 2023
Researchers used whole-genome sequencing and a 152-gene panel to study the DNA of patients with high-risk UTUC.
Read More
IHC Screening, AMS II Identify Lynch Syndrome in Patients With UTUC
Katy Marshall
Upper Tract Urothelial Carcinoma
|
October 26, 2023
Investigators performed IHC of 4 DNA mismatch repair gene-related proteins (MMRPs) on all UTUC specimens.
Read More
Experts Surveyed on Ideal Laser Setting During Endoscopic UTUC Treatment
Emily Menendez
Upper Tract Urothelial Carcinoma
|
October 13, 2023
In URS and RIRS, pulse shapes were significantly different, with Ho:YAG being used in long-pulse and TFL in short-pulse mode.
Read More
Nomogram Predicts Probability of Extraurothelial Recurrence in UTUC After RNU
Emily Menendez
Upper Tract Urothelial Carcinoma
|
September 22, 2023
The novel nomogram demonstrated perfect performance in discrimination ability and clinical net benefit.
Read More
Patients Over 70 Who Undergo Radical Nephroureterectomy for UTUC May Have Worse Outcomes
Emily Menendez
Upper Tract Urothelial Carcinoma
|
September 8, 2023
Older patients over 70 years of age need improved care and management of UTUC to improve their outcomes.
Read More
Platinum, Gemcitabine Combination Improves OS, CSS in UTUC
Emily Menendez
Upper Tract Urothelial Carcinoma
|
August 18, 2023
Patients who had initiated AC 90 days after RNU were examined to determine a relation between treatment efficacy and timing.
Read More
Expert Insights on Lymph Node Dissection, Kidney-Sparing Management
David Ambinder, MD
Upper Tract Urothelial Carcinoma
|
July 31, 2023
Dr. Surena F. Matin shared valuable insights on lymph node dissection and kidney-sparing management for UTUC.
Read More
Impact of the OLYMPUS Trial on Nephron-Sparing Management for Upper Tract Disease
David Ambinder, MD
Upper Tract Urothelial Carcinoma
|
July 31, 2023
Dr. Katie S. Murray provided insight into identifying candidates for kidney-sparing management of upper tract disease.
Read More
ROBUUST Database Shows Impact of Variant Histology on UTUC Outcomes
Emily Menendez
Upper Tract Urothelial Carcinoma
|
July 13, 2023
The implications of VH have been thoroughly studied in bladder cancer, but further investigation is needed in UTUC.
Read More
The OLYMPUS Trial for Patients With Low-Grade UTUC
Surena F. Matin, MD
Upper Tract Urothelial Carcinoma
|
August 15, 2023
Does the OLYMPUS trial have practice-changing potential for patients with low-grade, low-volume UTUC?
View More
Kidney Sparing in UTUC: The Right Patients and Optimal Techniques
Surena F. Matin, MD
Upper Tract Urothelial Carcinoma
|
July 28, 2023
Breaking down kidney-sparing management for UTUC, ideal patients, and SOC for endoscopic resection or ureter resection.
View More
Lymphadenectomy for UTUC: Staging and Therapeutic Considerations
Surena F. Matin, MD
Upper Tract Urothelial Carcinoma
|
July 24, 2023
Data supporting lymph node dissection at time of surgery for UTUC, as well as the risk factors for individual patients.
View More
Mitomycin Gel AEs and Administration in the Community Setting
Katie S. Murray, DO
Upper Tract Urothelial Carcinoma
|
July 24, 2023
Detailing the mitomycin gel adverse events, as well as advice for private practice urologists when offering mitomycin gel.
View More
Effective Techniques for Nephron Sparing, Mitomycin Gel for UTUC
Katie S. Murray, DO
Upper Tract Urothelial Carcinoma
|
July 24, 2023
Ideal candidates for nephron sparing management for upper tract disease, as well as candidates for mitomycin gel.
View More
ICIs, ADCs, and VEGF Inhibitors in Upper Tract Urothelial Disease
Petros Grivas, MD, PhD
Upper Tract Urothelial Carcinoma
|
July 24, 2023
ICIs for upper tract disease after upfront chemotherapy, along with the emerging role of targeted therapies.
View More
Load More
Advertisement
Advertisement
Advertisement